Seven-year follow-up after dobutamine stress echocardiography
Impact of gender on prognosis
Elena Biagini, MD*, ,
Abdou Elhendy, MD, FACC ,
Jeroen J. Bax, MD ,
Vittoria Rizzello, MD*,
Arend F.L. Schinkel, MD*,
Ron T. van Domburg, PhD*,
Miklos D. Kertai, MD*,
Boudewijn J. Krenning, MD*,
Manolis Bountioukos, MD*,
Claudio Rapezzi, MD ,
Angelo Branzi, MD ,
Maarten L. Simoons, MD, FACC* and
Don Poldermans, MD*,*
* *Department of Cardiology, Thoraxcenter, Erasmus MC, Rotterdam, the Netherlands
Institute of Cardiology, S. Orsola Hospital, Bologna, Italy
University of Nebraska Medical Center, Omaha, Nebraska
Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands

View larger version (16K):
[in a new window]
|
Figure 1 Kaplan-Meier survival curves (end point of hard cardiac events) in men and women with normal dobutamine stress echocardiography.
|
|

View larger version (14K):
[in a new window]
|
Figure 2 Kaplan-Meier survival curves (end point of hard cardiac events) in men according to results of dobutamine stress echocardiography.
|
|

View larger version (14K):
[in a new window]
|
Figure 3 Kaplan-Meier survival curves (end point of hard cardiac events) in women according to results of dobutamine stress echocardiography.
|
|
|